ELAVL1 and liver cancer: In line with previous research, LINC01018 acts as a novel suppressor for liver cancer by dint of its inhibiting effect on proliferation and promoting effect on apoptosis of liver cancer cells via miR‐182‐5p44; also, it serves as a sponge of miRNA in cancers and modulates the expressions of genes involved in fatty acid oxidation in livers via interacting with HuR.43